• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    Novo Nordisk A/S (NVO)

    44.98 Down 0.51(1.12%) 4:02PM EST
    |After Hours : 44.98 0.00 (0.00%) 5:16PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Novo Nordisk A/S
    Novo All
    Bagsvaerd, 2880
    Denmark - Map
    Phone: 45 44 44 88 88
    Fax: 45 44 49 05 55
    Website: http://www.novonordisk.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:40,700

    Business Summary 

    Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Novo Nordisk A/S

    Key Executives 
    Mr. Lars Rebien Sørensen , 61
    Chief Exec. Officer and Member of Exec. Management
    Mr. KÃ¥re Schultz , 54
    Pres, Chief Operating Officer and Member of Exec. Management
    Mr. Jesper Brandgaard MSc, 52
    Chief Financial Officer, Exec. VP, Member of Exec. Management, Chairman of The Board - Novo Nordisk Engineering A/S and Chairman of The Board - Novo Nordisk IT A/S
    Dr. Mads Krogsgaard Thomsen Ph.D., 55
    Chief Science Officer, Exec. VP and Member of Exec. Management
    Mr. Jakob Riis , 49
    Exec. VP of Marketing, Medical Affairs & Corp. Stakeholder Engagement and Member of Exec. Management
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.